window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : February 16, 2026

  • News
  • About Us
Contact Us

AASLD 2025

  • Chronic diseases,Clinical Development,Clinical Trials,Drug Development,Pharmaceuticals and therapeutics,Research & Development

    nChroma Bio presents preclinical data showing epigenetic silencing approach as potential functional cure for chronic hepatitis B

    nChroma Bio has presented new preclinical data supporting its lead [...]

    November 7, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Syngene collaborates with Johns Hopkins University to advance early-stage drug discovery
    Categories: Clinical Development, Drug Development, European biotech, Partnerships & Funding, Pharmaceuticals and therapeutics, Research & Development
  • QDX opens Gordon Bell-winning EXESS quantum chemistry engine to academic researchers
    Categories: Drug discovery, Technology and platforms
  • IgniteData appoints Laura Hilty as CSO and Joe Lengfellner as CPO amid Series A funding close
    Categories: Clinical Development, Data Management, Digital Health, Movers & Shakers, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top